Dr. Vedat Deviren, MD

Dr. Deviren practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Deviren's NPI, 1730230459, was assigned on January 16, 2007. Dr. Deviren graduated from Hacettepe University FOM in 1994. Dr. Deviren holds California license A86860.

Dr. Deviren's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Deviren's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Deviren to 1 more group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deviren practices, 3 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Deviren's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Deviren is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dr. Deviren is licensed in California.

Dmand AI lists spinal fusion among the conditions Dr. Deviren treats.

CMS data shows 1,073 Medicare services from Dr. Deviren across 16 procedure codes in 2024, for 171 Medicare patients. Medicare paid $275,934 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 171 Medicare patients who saw Dr. Deviren in 2024. The largest group is 65 to 74, with 82 patients. 75% of them have arthritis, and 75% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Deviren's median patient age at 70, with 50% women.

In 2024, Dr. Deviren wrote 19 Medicare Part D claims. 100% of them were for generic drugs. They cover 2 drugs, with $356 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Deviren for performance year 2024, reported as part of a group. Dr. Deviren accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Deviren as offering telehealth. CMS counts 451 procedures of spinal fusion by Dr. Deviren, more than 98% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 185 papers to Dr. Deviren, published from 2004 to 2025. 2018 was the busiest year, with 10. The most frequent topics are Spinal Fusion, Thoracic Vertebrae and Postoperative Complications. Dr. Deviren has published most often in J Neurosurg Spine. Dr. Deviren's most frequent co-authors are Christopher P. Ames, MD, Sigurd Harald Berven, MD and Shane Burch, MD.

Dmand AI links Dr. Deviren to 1 clinical trial. Conditions studied include Spondylolisthesis and Spondylolysis.

CMS Open Payments shows 822 general payments to Dr. Deviren from 23 drug and device companies from 2016 to 2025. Royalties and licenses make up the largest share, 83% of the total. Nuvasive, Inc. paid the most, $2,761,089.

Dmand AI lists 8 awards for Dr. Deviren, most recently Prize in Basic Science in 2017.

Dr. Deviren graduated from Hacettepe University FOM in 1994.

Dr. Deviren is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.